scholarly journals Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection

Hepatology ◽  
2010 ◽  
Vol 53 (3) ◽  
pp. 1067-1068 ◽  
Author(s):  
Martin Lagging ◽  
Åsa Alsiö ◽  
Nina Langeland ◽  
Court Pedersen ◽  
Martti Färkkilä ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Hepatitis C Virus Rna ◽  
Virus Genotype ◽  
Duration Of Therapy ◽  
Virus Rna ◽  
Genotype 2 ◽  
Chronic Hepatitis C Virus

scholarly journals Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

2016 ◽  
Vol 10 (2) ◽  
pp. 417-422 ◽  
Author(s):  
Akira Sato ◽  
Toshiya Ishii ◽  
Kayo Adachi ◽  
Hideaki Takahashi ◽  
Fumiaki Sano ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Viral Clearance ◽  
Hepatitis C Virus Infection ◽  
Hepatitis C Virus Rna ◽  
Virus Genotype ◽  
Virus Rna ◽  
Chronic Hepatitis C Virus

Following interferon-based therapy for chronic hepatitis C, the negativity of hepatitis C virus RNA is essential to achieve viral clearance at the end of treatment. We report a case of clearance of chronic hepatitis C virus infection following early discontinuation (at 6 weeks) of peginterferon plus ribavirin therapy, without negativity for hepatitis C virus RNA during the treatment period. The patient was a 76-year-old Japanese male infected with hepatitis C virus genotype 1b and TT of IL28B rs8099917. Hepatitis C virus RNA remained positive at persistently low levels for more than 2 months after the cessation of therapy and became negative at 7 months after the discontinuation of therapy. Spontaneous clearance of hepatitis C virus RNA can occur following antiviral failure in patients with persistently low viral loads, and virological follow-up is therefore necessary in chronic hepatitis C virus infection, even after antiviral failure.

scholarly journals Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

2016 ◽  
Vol 62 (10) ◽  
pp. 1228-1234 ◽  
Author(s):  
Johannes Vermehren ◽  
Benjamin Maasoumy ◽  
Raoel Maan ◽  
Gavin Cloherty ◽  
Caterina Berkowski ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Viral Load ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Genotype 1 ◽  
Hepatitis C Virus Rna ◽  
Virus Genotype ◽  
Virus Rna ◽  
Chronic Hepatitis C Virus

scholarly journals Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

2012 ◽  
Vol 19 (9) ◽  
pp. 623-634 ◽  
Author(s):  
S. Pianko ◽  
S. Zeuzem ◽  
W.-L. Chuang ◽  
G. R. Foster ◽  
S. K. Sarin ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Randomized Trial ◽  
Chronic Hepatitis C ◽  
Virus Genotype ◽  
Genotype 2 ◽  
Chronic Hepatitis C Virus

Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

Hepatology ◽  
2008 ◽  
Vol 47 (6) ◽  
pp. 1837-1845 ◽  
Author(s):  
Martin Lagging ◽  
Nina Langeland ◽  
Court Pedersen ◽  
Martti Färkkilä ◽  
Mads Rauning Buhl ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Virus Genotype ◽  
Genotype 2 ◽  
Chronic Hepatitis C Virus ◽  
Peginterferon Α
Sign in / Sign up

Export Citation Format

Share Document